Palo Alto, CA, United States of America

Jason Bell

This inventor holds 17 USPTO granted patents and 19 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in RNA Processing. Top assignees: 10X Genomics, Inc., Zsm Holdings LLC. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason Bell. Retrieved from https://idiyas.com/inventor/jason-bell-lgox6uq7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 200(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2020 - 2024)
  • Frederick, CO (US) (2022 - 2024)
  • Boulder, CO (US) (2024)

Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
RNA Processing
Aircraft Fuselage
Chromatin Analysis
Cargo Loading
Transposon Loading
Nucleic Acid Processing
Payload Reservation
Barcode Exchange
17 patents (USPTO):Explore Patents

Title: Jason Bell - Innovator in Transposon Technology

Introduction

Jason Bell is a prominent inventor based in Palo Alto, CA. He has made significant contributions to the field of biotechnology, particularly in the area of transposon technology. With a total of 17 patents, his work has advanced the understanding and application of genetic engineering.

Latest Patents

Among his latest patents, Jason has developed systems and methods for transposon loading. This invention provides methods, compositions, and systems for loading transposons with nucleic acid molecules, facilitating transposition reactions of cellular nucleic acids. The present invention aims to improve transposon loading and the yield of productive fragments while minimizing potential nucleic acid fragment loss or cross-contamination. Another notable patent focuses on methods and systems to minimize barcode exchange during the preparation of barcoded next-generation sequencing libraries from a single cell. These methods utilize oligonucleotides containing a 3'-terminated blocking group or sequences that prevent amplification or extension.

Career Highlights

Jason has worked with notable companies in the biotechnology sector, including 10x Genomics, Inc. and 10x Genomics, Inc. His innovative approaches have positioned him as a key player in the development of advanced genetic technologies.

Collaborations

Throughout his career, Jason has collaborated with talented individuals such as Francesca Meschi and Geoffrey McDermott. These partnerships have contributed to the success of his projects and the advancement of the field.

Conclusion

Jason Bell's contributions to transposon technology and genetic engineering have made a lasting impact on the industry. His innovative patents and collaborations continue to shape the future of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…